Obstetrics & Gynecology

Obstetrics & gynaecology

Elagolix reduces menstrual bleeding from most common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States—benign tumors that disproportionately affect African-Americans, an international clinical trial ...

Oncology & Cancer

Ultrasound ovarian cancer screening improves survival

A University of Kentucky study just published in Obstetrics & Gynecology shows that annual ultrasound screening of at-risk asymptomatic women increases the survival rates of women with type I and type II epithelial ovarian ...

Obstetrics & gynaecology

Accepted manuscripts meet more criteria for research reporting

(HealthDay)—Accepted manuscripts for observational studies have better adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist compared with rejected manuscripts, according ...

Surgery

Opioid use down with 'enhanced recovery after surgery' program

(HealthDay)—An "enhanced recovery after surgery" (ERAS) program is associated with a significant reduction in opioid consumption after gynecologic surgery with no increase in pain scores, according to a study published ...

Obstetrics & gynaecology

Ondansetron in pregnancy not linked to most birth defects

(HealthDay)—Use of ondansetron for the treatment of nausea and vomiting in pregnancy does not appear to be associated with birth defects, according to research published in the August issue of Obstetrics & Gynecology.

Obstetrics & gynaecology

No benefit to negative pressure wound therapy after C-section

(HealthDay)—For obese women, use of prophylactic negative pressure wound therapy versus standard dressings does not reduce superficial surgical site infections after cesarean section, according to a study published in the ...

page 15 from 40